The upstream bioprocessing market is experiencing unprecedented growth, with projections indicating a surge from USD 24.16 billion in 2023 to an astounding USD 105.30 billion by 2034. This remarkable expansion is driven by several key factors, including the rising demand for biopharmaceuticals,
Engineered virus-like particles (eVLPs) are revolutionizing the field of gene delivery and editing. These particles are designed to safely and effectively deliver macromolecules, such as mRNAs, proteins, or ribonucleoproteins (RNPs), into cells. While Adeno-associated virus (AAV) vectors have been
Growth hormone-releasing hormone (GHRH), also known as somatoliberin, has emerged as a significant focus in medical research due to its extensive biological activities and therapeutic potential. GHRH, a family of hypothalamic peptide hormones, plays a crucial role in stimulating and modulating the
Triple-negative breast cancer (TNBC) is known for its aggressive nature and limited treatment options. However, a recent breakthrough in personalized immunotherapy offers new hope for patients. Researchers have developed a neoantigen DNA vaccine platform that has shown promising results in
Spermidine, a naturally occurring polyamine, has attracted significant attention in scientific research for its potential role in combating diabetes and the vascular complications that arise from this condition. A recent study published in Nature Cell Biology delves into how spermidine influences
Some studies presents an in-depth analysis of how the density of microorganisms, or microbial load, in the human gut can impact overall health and contribute to various diseases. This relatively new dimension of gut microbiome research, as illustrated by the study conducted by the Bork group at
